Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): study protocol for a hybrid type 2 effectiveness-implementation trial
In November 2021, the REVERSE study was registered with the "International Standard Randomised Controlled Trial Number" (ISRCTN) register under nr.12956554.
Authors
- Walter Zingg (ORCID: https://orcid.org/0009-0003-7438-1213)
- Laura Caci
- Ashlesha Sonpar (ORCID: https://orcid.org/0000-0003-1676-1384)
- Greet J. Boland
- Kathrin Blum (ORCID: https://orcid.org/0000-0002-4383-0528)
- Pilar Retamar (ORCID: https://orcid.org/0000-0003-2147-809X)
- Jack Pollard
- Elena Carrara (ORCID: https://orcid.org/0000-0003-1004-515X)
- Bianca Albers (ORCID: https://orcid.org/0000-0001-9555-0547)
- Vered Schechner (ORCID: https://orcid.org/0000-0002-7441-931X)
- Takuya Yanagida (ORCID: https://orcid.org/0000-0001-9052-4841)
- Aude Nguyen
- Lauren Clack on behalf of the REVER Consortium
Institutions
- University of Verona (IT)
- University of Vienna (AT)
- Tel Aviv University (IL)
- Environment Agency (GB)
- University of Zurich (CH)
- Instituto de Salud Carlos III (ES)
- Israel Ministry of Health (IL)
- University Medical Center Utrecht (NL)
- University Hospital of Zurich (CH)
- University Hospital of Geneva (CH)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Biomedicina de Sevilla (ES)
Publication Details
- Journal
- Trials
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1186/s13063-025-09132-x
- Citations
- 1
- Primary Topic
- Health Policy Implementation Science
- Type
- article
- Field-Weighted Citation Impact
- 2.82
Funders
- European Commission